AC Immune (ACIU) Exchange Rate Effect (2015 - 2025)
AC Immune (ACIU) posted quarterly Exchange Rate Effect of -$225210.6 for Q4 2025, down 110.13% year-over-year from $2.2 million in Q4 2024, and down 1101.02% quarter-over-quarter from -$18751.6 in Q3 2025.
Powered by 
Analysis
AC Immune (ACIU) Exchange Rate Effect (2015 - 2025) Analysis & Trends
AC Immune (ACIU) has reported Exchange Rate Effect for 11 consecutive years, with -$225210.6 the latest figure, recorded in Q4 2025.
- In Q4 2025, Exchange Rate Effect fell 110.13% year-over-year to -$225210.6; the TTM figure through Dec 2025 stood at -$3.3 million (down 80.94% YoY), while the FY2025 annual figure was -$3.3 million, down 75.35% from the prior year.
- Exchange Rate Effect fell to -$225210.6 in Q4 2025 per ACIU's latest filing, from -$18751.6 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $2.2 million in Q4 2024 and bottomed at -$3.2 million in Q3 2024.
- Historically, Exchange Rate Effect has averaged -$320249.0 across 5 years, with a median of -$48858.1 in 2025.
- On a YoY basis, Exchange Rate Effect climbed as much as 18538.37% in 2024 and fell as far as 5479.72% in 2024.
- AC Immune's Exchange Rate Effect stood at -$597560.7 in 2021, then surged by 44.76% to -$330091.0 in 2022, then plunged by 429.37% to -$1.7 million in 2023, then soared by 227.19% to $2.2 million in 2024, then plunged by 110.13% to -$225210.6 in 2025.
- Business Quant data shows ACIU's Exchange Rate Effect at -$225210.6 in Q4 2025, -$18751.6 in Q3 2025, and -$2.7 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | AC Immune | 285.13 Mn | 285.13 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -225,210.56 |
| Sep 30, 2025 | -18,751.64 |
| Jun 30, 2025 | -2.75 Mn |
| Mar 31, 2025 | -299,195.39 |
| Dec 31, 2024 | 2.22 Mn |
| Sep 30, 2024 | -3.17 Mn |
| Jun 30, 2024 | -2.87 Mn |
| Mar 31, 2024 | 1.99 Mn |
| Dec 31, 2023 | -1.75 Mn |
| Sep 30, 2023 | 58,871.93 |
| Jun 30, 2023 | -78,964.46 |
| Mar 31, 2023 | -10,811.63 |
| Dec 31, 2022 | -330,090.97 |
| Sep 30, 2022 | 161,531.24 |
| Jun 30, 2022 | 482,806.25 |
| Mar 31, 2022 | 236,052.23 |
| Dec 31, 2021 | -597,560.66 |
| Sep 30, 2021 | 128,517.23 |
| Jun 30, 2021 | -282,934.96 |
| Mar 31, 2021 | 686,862.68 |